Walleye Capital LLC 4 D Molecular Therapeutics, Inc. Transaction History

Walleye Capital LLC

  • $54.6 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$6.85 - $25.46 $115,895 - $430,757
16,919 New
16,919 $375,000
Q2 2022

Aug 08, 2022
BUY
$5.68 - $15.99 $159,426 - $448,807
28,068 New
28,068 $196,000
Q3 2021

Nov 15, 2021
SELL
$22.73 - $36.04 $277,419 - $439,868
-12,205 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$22.2 - $42.29 $270,951 - $516,149
12,205 New
12,205 $294,000

Others Institutions Holding FDMT

# of Institutions
157
Shares Held
50.3M
Call Options Held
718K
Put Options Held
370K
View Full List

About 4D Molecular Therapeutics, Inc.

FDMT Quotes by TradingView
  • Ticker FDMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,382,400
  • Market Cap $675M
  • Description
  • 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...
More about FDMT
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email